Abstract
Parkinson’s disease (PD) is a progressive nervous system disorder that leads to stiffness, shaking, and difficulty with balance, walking, and coordination. Apomorphine is a dopamine agonist that is thought to play a role in off states and motor function improvement in patients with Parkinson's disease (PD). In this systematic review, we aimed to synthesize evidence from published clinical trials on the efficacy and safety of the administration of apomorphine in PD patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
